Juncture Wealth Strategies’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-16,301
Closed -$450K – 103
2020
Q1
$450K Sell
16,301
-2,169
-12% -$65K 0.42% 57
2019
Q4
$540K Buy
18,470
+3,370
+22% +$80.3K 0.42% 61
2019
Q3
$289K Buy
+15,100
New +$354K 0.25% 88

Other funds holding NEO

Juncture Wealth Strategies's NEO Position: Q2 2020 in Review

Juncture Wealth Strategies sold out of NeoGenomics (NEO) in Q2 2020, closing a stake of 16,301 shares — an estimated $450K sold.

Juncture Wealth Strategies first reported a position in NEO in Q3 2019 and held it in 3 quarters. The position peaked at $540K in Q4 2019. 285 funds tracked by Wall St. Rank hold NEO as of Q2 2020.

  • Juncture Wealth Strategies reported no remaining NeoGenomics position as of Q2 2020 after selling out during the quarter.
  • Juncture Wealth Strategies sold 16,301 NeoGenomics shares in Q2 2020, an estimated $450K.
  • Juncture Wealth Strategies first reported a position in NeoGenomics in Q3 2019 and held it in 3 quarters.
  • Juncture Wealth Strategies's NeoGenomics position peaked at $540K in Q4 2019.
  • 285 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2020.

Based on Juncture Wealth Strategies's 13F filing for Q2 2020, filed 28 Jul 2020.